Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.

De Palma G, Lynch MD, Lu J, Dang VT, Deng Y, Jury J, Umeh G, Miranda PM, Pigrau Pastor M, Sidani S, Pinto-Sanchez MI, Philip V, McLean PG, Hagelsieb MG, Surette MG, Bergonzelli GE, Verdu EF, Britz-McKibbin P, Neufeld JD, Collins SM, Bercik P.

Sci Transl Med. 2017 Mar 1;9(379). pii: eaaf6397. doi: 10.1126/scitranslmed.aaf6397.

PMID:
28251905
2.

Targeting the microbiota-gut-brain axis to modulate behavior: which bacterial strain will translate best to humans?

McLean PG, Bergonzelli GE, Collins SM, Bercik P.

Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):E174; author reply E176. doi: 10.1073/pnas.1118626109. Epub 2012 Jan 13. No abstract available.

3.

The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication.

Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, Berger B, Huizinga JD, Kunze W, McLean PG, Bergonzelli GE, Collins SM, Verdu EF.

Neurogastroenterol Motil. 2011 Dec;23(12):1132-9. doi: 10.1111/j.1365-2982.2011.01796.x. Epub 2011 Oct 11.

4.

Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice.

Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, Lu J, Khan WI, Corthesy-Theulaz I, Cherbut C, Bergonzelli GE, Collins SM.

Gastroenterology. 2010 Dec;139(6):2102-2112.e1. doi: 10.1053/j.gastro.2010.06.063. Epub 2010 Jun 27.

PMID:
20600016
5.

Yeast, beef and pork extracts counteract Clostridium difficile toxin A enterotoxicity.

Duncan PI, Fotopoulos G, Pasche E, Porta N, Masserey Elmelegy I, Sanchez-Garcia JL, Bergonzelli GE, Corthésy-Theulaz I.

FEMS Microbiol Lett. 2009 Jun;295(2):218-25. doi: 10.1111/j.1574-6968.2009.01598.x. Epub 2009 Apr 14.

6.

Maternal deprivation affects the neuromuscular protein profile of the rat colon in response to an acute stressor later in life.

Lopes LV, Marvin-Guy LF, Fuerholz A, Affolter M, Ramadan Z, Kussmann M, Fay LB, Bergonzelli GE.

J Proteomics. 2008 Apr 30;71(1):80-8. doi: 10.1016/j.jprot.2008.01.007. Epub 2008 Jan 18.

PMID:
18541476
7.

Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats.

Eutamene H, Lamine F, Chabo C, Theodorou V, Rochat F, Bergonzelli GE, Corthésy-Theulaz I, Fioramonti J, Bueno L.

J Nutr. 2007 Aug;137(8):1901-7.

PMID:
17634262
8.

Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation.

Martin FP, Verdu EF, Wang Y, Dumas ME, Yap IK, Cloarec O, Bergonzelli GE, Corthesy-Theulaz I, Kochhar S, Holmes E, Lindon JC, Collins SM, Nicholson JK.

J Proteome Res. 2006 Sep;5(9):2185-93.

PMID:
16944930
9.

Nutritional approach to restore impaired intestinal barrier function and growth after neonatal stress in rats.

García-Ródenas CL, Bergonzelli GE, Nutten S, Schumann A, Cherbut C, Turini M, Ornstein K, Rochat F, Corthésy-Theulaz I.

J Pediatr Gastroenterol Nutr. 2006 Jul;43(1):16-24.

PMID:
16819372
10.

-Omics for prevention: gene, protein and metabolite profiling to better understand individual disposition to disease.

Affolter M, Bergonzelli GE, Blaser K, Blum-Sperisen S, Corthésy B, Fay LB, Garcia-Rodenas C, Lopes LV, Marvin-Guy L, Mercenier A, Mutch DM, Panchaud A, Raymond F, Schmidt-Weber C, Schumann A, Spertini F, Williamson G, Kussmann M.

Nestle Nutr Workshop Ser Pediatr Program. 2006;57:247-50; discussion 250-5. Review. No abstract available.

PMID:
16632970
11.

GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori.

Bergonzelli GE, Granato D, Pridmore RD, Marvin-Guy LF, Donnicola D, Corthésy-Theulaz IE.

Infect Immun. 2006 Jan;74(1):425-34.

12.

Probiotics as a treatment strategy for gastrointestinal diseases?

Bergonzelli GE, Blum S, Brussow H, Corthésy-Theulaz I.

Digestion. 2005;72(1):57-68. Epub 2005 Aug 18. Review.

PMID:
16113543
13.

Proteomics of the rat gut: analysis of the myenteric plexus-longitudinal muscle preparation.

Marvin-Guy L, Lopes LV, Affolter M, Courtet-Compondu MC, Wagnière S, Bergonzelli GE, Fay LB, Kussmann M.

Proteomics. 2005 Jul;5(10):2561-9.

PMID:
15984044
14.

Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction.

Verdú EF, Bercík P, Bergonzelli GE, Huang XX, Blennerhasset P, Rochat F, Fiaux M, Mansourian R, Corthésy-Theulaz I, Collins SM.

Gastroenterology. 2004 Sep;127(3):826-37.

PMID:
15362038
15.

Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins.

Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, Corthésy-Theulaz IE.

Infect Immun. 2004 Apr;72(4):2160-9.

16.

Essential oils as components of a diet-based approach to management of Helicobacter infection.

Bergonzelli GE, Donnicola D, Porta N, Corthésy-Theulaz IE.

Antimicrob Agents Chemother. 2003 Oct;47(10):3240-6.

17.

Interplay between galanin and leptin in the hypothalamic control of feeding via corticotropin-releasing hormone and neuropeptide Y.

Bergonzelli GE, Pralong FP, Glauser M, Cavadas C, Grouzmann E, Gaillard RC.

Diabetes. 2001 Dec;50(12):2666-72.

18.

Cloning and characterization of Helicobacter pylori succinyl CoA:acetoacetate CoA-transferase, a novel prokaryotic member of the CoA-transferase family.

Corthésy-Theulaz IE, Bergonzelli GE, Henry H, Bachmann D, Schorderet DF, Blum AL, Ornston LN.

J Biol Chem. 1997 Oct 10;272(41):25659-67.

19.

Plasminogen: an important hemostatic parameter in septic patients.

Duboscq C, Quintana I, Bassilotta E, Bergonzelli GE, Porterie P, Sassetti B, Haedo AS, Wainsztein N, Kruithof EK, Kordich L.

Thromb Haemost. 1997 Jun;77(6):1090-5.

PMID:
9241738
20.

Hypertension increases connexin43 in a tissue-specific manner.

Haefliger JA, Castillo E, Waeber G, Bergonzelli GE, Aubert JF, Sutter E, Nicod P, Waeber B, Meda P.

Circulation. 1997 Feb 18;95(4):1007-14.

PMID:
9054764
21.

Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.

Lupu F, Bergonzelli GE, Heim DA, Cousin E, Genton CY, Bachmann F, Kruithof EK.

Arterioscler Thromb. 1993 Jul;13(7):1090-100.

PMID:
7686395
22.
23.
24.

Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.

Bergonzelli GE, Kruithof EK.

J Cell Physiol. 1991 Aug;148(2):306-13.

PMID:
1652590
25.
26.

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.

Cajot JF, Bamat J, Bergonzelli GE, Kruithof EK, Medcalf RL, Testuz J, Sordat B.

Proc Natl Acad Sci U S A. 1990 Sep;87(18):6939-43.

27.

Mini-plasminogen like molecule in septic patients.

Kordich LC, Porterie VP, Lago O, Bergonzelli GE, Sassetti B, Sanchez Avalos JC.

Thromb Res. 1987 Sep 1;47(5):553-60.

PMID:
2445046

Supplemental Content

Loading ...
Support Center